Down 60% means it's a better-than-average time to average down That's not really even a big miss yet at this stage at least not in my experience.
Yes things are taking their time, but that is just the way of it / or w/o the Covid delays. We investors constantly have issues with timing and patience. How many winners have you sold short thinking the worst?
Alcoa is on board but not on the Board yet. But that's a certainty IF the FYI process is proven capable. The fact that Alcoa and FYI have joint IP is a real positive consideration imho. Every t must be crossed; every i dotted; as Alcoa is the ultimate in intelligent development; right up there with ExxonMobil. The attractiveness of the FYI process goes beyond the ESG greening - the process is not just greener but leaner. And if it can produce 5N out of the ground at any deposit, that's where it will be found.
I just wish I understood a little more about exactly what Alcoa was submitting as input to FYI's process.
- Forums
- ASX - By Stock
- CCM
- Ann: Investor Presentation - Brisbane Mining Conference
Ann: Investor Presentation - Brisbane Mining Conference, page-11
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCM (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.3¢ |
Change
0.001(1.61%) |
Mkt cap ! $23.36M |
Open | High | Low | Value | Volume |
6.4¢ | 6.9¢ | 6.2¢ | $14.68K | 227.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 173270 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 36438 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 173270 | 0.063 |
1 | 64769 | 0.062 |
2 | 35000 | 0.060 |
1 | 80000 | 0.059 |
1 | 8000 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 36438 | 1 |
0.067 | 130000 | 1 |
0.069 | 86206 | 3 |
0.070 | 110013 | 4 |
0.071 | 3000 | 1 |
Last trade - 15.18pm 15/07/2024 (20 minute delay) ? |
Featured News
CCM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online